Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation
- PMID: 15604218
- DOI: 10.1182/blood-2004-10-4072
Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation
Abstract
Monocyte cytokines (ie, monokines) induce natural killer (NK) cells to produce interferon-gamma (IFN-gamma), which is critical for monocyte clearance of infectious pathogens and tumor surveillance. Human CD56bright NK cells produce far more IFN-gamma in response to monokines than do CD56dim NK cells. The kinases and phosphatases involved in regulating IFN-gamma production by monokine-activated NK cells are not clearly identified. SHIP1 is a 5' inositol phosphatase that dephosphorylates the phosphatidylinositol-3 kinase (PI-3K) product PI3,4,5P3. Here, we show that constitutive expression of SHIP1 is distinctly lower in CD56bright NK cells compared with CD56dim NK cells, suggesting it could be an important negative regulator of IFN-gamma production in monokine-activated NK cells. Indeed, overexpression of SHIP1 in CD56bright NK cells followed by monokine activation substantially lowered IFN-gamma production. This effect was not seen when NK cells were infected with a SHIP1 mutant containing an inactive catalytic domain. Finally, NK cells in SHIP1-/- mice produced more IFN-gamma in response to monokines in vivo than did NK cells from wild-type mice. Collectively, these results demonstrate that SHIP1 negatively regulates monokine-induced NK cell IFN-gamma production in vitro and in vivo and provide the first molecular explanation for an important functional distinction observed between CD56bright and CD56dim human NK subsets.
Similar articles
-
Src homology 2-containing inositol 5'-phosphatase 1 negatively regulates IFN-gamma production by natural killer cells stimulated with antibody-coated tumor cells and interleukin-12.Cancer Res. 2005 Oct 1;65(19):9099-107. doi: 10.1158/0008-5472.CAN-04-4424. Cancer Res. 2005. PMID: 16204085
-
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production.J Exp Med. 2007 Oct 1;204(10):2397-405. doi: 10.1084/jem.20070419. Epub 2007 Sep 17. J Exp Med. 2007. PMID: 17875674 Free PMC article.
-
miR-155 regulates IFN-γ production in natural killer cells.Blood. 2012 Apr 12;119(15):3478-85. doi: 10.1182/blood-2011-12-398099. Epub 2012 Feb 29. Blood. 2012. PMID: 22378844 Free PMC article.
-
The role of SHIP1 in macrophage programming and activation.Biochem Soc Trans. 2004 Nov;32(Pt 5):785-8. doi: 10.1042/BST0320785. Biochem Soc Trans. 2004. PMID: 15494015 Review.
-
Role of SHIP1 in bone biology.Ann N Y Acad Sci. 2013 Mar;1280:11-4. doi: 10.1111/nyas.12091. Ann N Y Acad Sci. 2013. PMID: 23551095 Free PMC article. Review.
Cited by
-
Phosphatidylinositol-3-phosphate kinase pathway activation protects leukemic large granular lymphocytes from undergoing homeostatic apoptosis.Blood. 2006 Jun 15;107(12):4834-40. doi: 10.1182/blood-2005-08-3076. Epub 2006 Feb 16. Blood. 2006. PMID: 16484592 Free PMC article.
-
Hlx homeobox transcription factor negatively regulates interferon-gamma production in monokine-activated natural killer cells.Blood. 2007 Mar 15;109(6):2481-7. doi: 10.1182/blood-2006-10-050096. Epub 2006 Nov 16. Blood. 2007. PMID: 17110450 Free PMC article.
-
Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5941-6. doi: 10.1073/pnas.0601335103. Epub 2006 Apr 3. Proc Natl Acad Sci U S A. 2006. PMID: 16585503 Free PMC article. Clinical Trial.
-
A role for SHIP in stem cell biology and transplantation.Curr Stem Cell Res Ther. 2008 May;3(2):99-106. doi: 10.2174/157488808784223050. Curr Stem Cell Res Ther. 2008. PMID: 18473876 Free PMC article. Review.
-
TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.J Immunol. 2008 Sep 15;181(6):3784-92. doi: 10.4049/jimmunol.181.6.3784. J Immunol. 2008. PMID: 18768831 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous